University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology and University of Texas at Houston - MD Anderson Cancer Center

Tennessee Oncology - Sarah Cannon Research Institute, Curtin University, Harvard Medical School - Massachusetts General Hospital Cancer Center, Highlands Oncology Group, Yonsei University Health System - Severance Hospital, KU Leuven - Department of Gynecologic Oncology, University of Texas at Houston - Department of Breast Medical Oncology, Seoul National University - Department of Internal Medicine, BC Cancer Agency (BCCA), NYU Langone Health, Sarah Cannon Research Institute - Florida Cancer Specialists, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation and Tennessee Oncology - Sarah Cannon Research Institute